Oncology / Cancer Therapies
Revolution Medicines' Proactive Strategy for RAS Therapy and Recent Data
RAS therapies are a focus in cancer research. Revolution Medicines is proactively addressing potential resistance, and recent data highlights the landscape of KRAS inhibitors.